Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
11 - 20 out of 59Page size: 10
Sort by: 1st author
  1. Published

    A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R. & 42 others, Kruszewski, M., Martinez-Lopez, J., Beider, K., Iskierka-Jazdzewska, E., Pelosini, M., Berndt, S. I., Raźny, M., Jamroziak, K., Rajkumar, S. V., Jurczyszyn, A., Vangsted, Annette Juul, Collado, P. G., Vogel, U., Hofmann, J. N., Petrini, M., Butrym, A., Slager, S. L., Ziv, E., Subocz, E., Giles, G. G., Andersen, N. F., Mazur, G., Watek, M., Lesueur, F., Hildebrandt, M. A. T., Zawirska, D., Ebbesen, L. H., Marques, H., Gemignani, F., Dumontet, C., Várkonyi, J., Buda, G., Nagler, A., Druzd-Sitek, A., Wu, X., Kadar, K., Camp, N. J., Grzasko, N., Waller, R. G., Vachon, C., Canzian, F. & Campa, D., 2023, In: International Journal of Cancer. 152, 2, p. 239-248 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

    Erickson, S. W., Stephens, O. W., Chavan, S. S., Epstein, J., Barlogie, B., Heuck, C. J. & Vangsted, Annette Juul, Sep 2016, In: British Journal of Haematology. 174, 6, p. 991-993 3 p.

    Research output: Contribution to journal › Comment/debate › Research

  3. Published

    The Danish National Multiple Myeloma Registry

    Gimsing, P., Holmström, M. O., Klausen, T. W., Andersen, N. F., Gregersen, H., Pedersen, R. S., Plesner, T., Pedersen, P. T., Frederiksen, M., Frølund, U. C., Helleberg, C., Vangsted, Annette Juul, Brown, Peter de Nully & Abildgaard, N., 25 Oct 2016, In: Clinical Epidemiology. 8, p. 583-587 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

    Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M. & 1 others, Gulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

    Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, Christen Bertel L, Klausen, T. W., Vangsted, Annette Juul & Abildgaard, N., 2018, In: Experimental Hematology & Oncology. 7, 1, 18.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study

    Gregersen, H., Vangsted, Annette Juul, Abildgaard, N., Andersen, N. F., Pedersen, R. S., Frølund, U. C., Helleberg, C., Broch, B., Pedersen, P. T., Gimsing, P. & Klausen, T. W., Jun 2017, In: Cancer Medicine. 6, 7, p. 1807-1816 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Potential value of pre-planned imaging of bone disease in multiple myeloma

    Nordic Myeloma Study Group, N. M. S. G., 2023, In: Blood Cancer Journal. 13, 1, 5 p., 105.

    Research output: Contribution to journal › Editorial › Research › peer-review

  8. Published

    Lenalidomide Maintenance in Multiple Myeloma: A Retrospective, Nationwide, Real-World Study

    Harsløf, Mads, Chanchiri, I., Silkjær, T., Frølund, U. C., Teodorescu, E. M., Nielsen, K. B., Nielsen, P. I., Pedersen, P. T., Iversen, K. F., Grønbæk, Kirsten, Vangsted, Annette Juul, Thorsteinsdottir, S. & Szabo, A. G., 2023, In: Blood. 142, Supplement 1, p. 1979 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014

    Helm-Petersen, S., Sørrig, R., Klausen, T. W., Preiss, B., Frølund, U. C., Helleberg, C., Breinholt, M., Andersen, M. K., Abildgaard, N., Gimsing, P. & Vangsted, Annette Juul, 2018, In: Leukemia. 32, p. 2054-2057

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation

    Hermansen, N. E. U., Borup, R., Andersen, M. K., Vangsted, Annette Juul, Clausen, T. N., Kristensen, D. L., Nielsen, Finn Cilius & Gimsing, P., Jun 2016, In: International Journal of Laboratory Hematology. 38, 3, p. 298-307 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 9762536